AK104 plus chemotherapy promising first-line option for gastric cancer Presented ByDr Jiafu Ji, Beijing Cancer Hospital, China TrialPhase 1/2, AK104-201 ConferenceASCO GI 2022 TypePeer-reviewed article 21 March 2022 11:19
Bispecific antibodies targeting PD-1 and CTLA-4: new kids on the block(ade) ConferenceESMO 2020 TypePeer-reviewed article 25 November 2020 12:45